Herbal extract for colon cancer

[Guest guest]

does anyone know if it is possible to obtain this Rhus Verniciflua

Stoke extract without going to Korea??

Karla

Impact of Standardized Rhus verniciflua Stokes Extract as Complementary Therapy

on Metastatic Colorectal Cancer: A Korean Single-Center Experience

Sang-hun Lee, PhD, OMD

Department of Clinical Oncology, College of Oriental Medicine, M.µ Integrative

Cancer Center, East-West Neo Medical Center Kyung Hee University, Seoul,

Republic of Korea

Won-cheol Choi, PhD, OMD

Department of Clinical Oncology, College of Oriental Medicine, M.µ Integrative

Cancer Center, East-West Neo Medical Center Kyung Hee University, Seoul,

Republic of Korea

Seong-woo Yoon, PhD, OMD

Department of Internal Medicine, M.µ Integrative Cancer Center, East-West Neo

Medical Center Kyung Hee University, Seoul, Republic of Korea,

stepano212@...

Background. To investigate the clinical feasibility of the standardized Rhus

verniciflua Stokes (RVS) extract for the metastatic colorectal cancer (mCRC),

experimentally proven to have anticancer activities. Patients and Methods. From

July 2006 to November 2007, patients with conventional chemotherapy refractory

mCRC were checked. After fulfilling inclusion/exclusion criteria, 36 patients

were eligible for the final analysis. Overall survival and adverse events of

patients treated with RVS in the aftercare period were determined. Results. On

October 21, 2008, a total of 26 patients died while the remaining 10 patients

were alive with evidence of disease. The median RVS administration period was

2.7 months (95% confidence interval, 1.9-3.5). The median overall survival for

the entire population was 10.9 months (95% confidence interval, 5.6-16.1) and

1-year survival rate was 44.4%, which is compatible with external controls. By

survival analysis using proportional hazards model, the performance status

and the prior chemotherapy regimen number significantly affected overall

survival. Adverse reactions to the RVS treatment were mostly mild and

self-limiting. Conclusion. Complementary treatment with the standardized RVS

extract might be beneficial for patients with mCRC, since it positively affected

overall survival without significant side effects. This study suggests that RVS

could be a natural anticancer agent candidate for the treatment of colorectal

adenocarcinoma.